ReNeuron Group plc - Wins grant for retinal cell therapy development

ReNeuron Group plc, a UK- based global leader in the development of cell-based therapeutics, is pleased to announce that it is the lead industry participant in a new £1.5 million grant award from the UK's innovation agency, Innovate UK, to advance development of its hRPC stem cell therapy candidate for blindness-causing degenerative diseases of the retina..